               SEQUENCE LISTING

<110> DISCUVA LTD 

<120> Process for Producing Bacterial Mutants

<150> GB1413202.1
<151> 2014-07-25

<160> 3

<170> BiSSAP 1.2

<210> 1
<211> 21
<212> DNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..21
<223> /mol_type="unassigned DNA"
      /note="5’ phosphorylated, 3’ dideoxy terminated DNA
      oligonucleotide RP-1 "
      /organism="Artificial Sequence"

<400> 1
aacctggaca tacgcatccg a                                              21


<210> 2
<211> 20
<212> DNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..20
<223> /mol_type="unassigned DNA"
      /note="reverse complement of the RP-1 oligo"
      /organism="Artificial Sequence"

<400> 2
cggatgcgta tgtccaggtt                                                20


<210> 3
<211> 21
<212> DNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..21
<223> /mol_type="unassigned DNA"
      /note="oligo with sequence specificity to the transposon in a
      region common to all promoters"
      /organism="Artificial Sequence"

<400> 3
cgactcacta tagggagatg t                                              21


